Compare CVS Health Corp (CVS) vs Transocean Ltd (RIG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Transocean Ltd — how do they compare? CVS Health Corp trades at $106.25 (market cap $135.48B), while Transocean Ltd trades at $5.18 (market cap $5.88B). The key difference: CVS Health Corp is far larger — about 23× Transocean Ltd's market cap, and CVS Health Corp pays a 2.51% dividend while Transocean Ltd pays none. Which is the better fit depends on your goals.
| CVS | RIG | |
|---|---|---|
Market Cap | $135.48B | $5.88B |
Sector | Health | Technology |
52-Week High | $106.18 | $7.58 |
52-Week Low | $58.75 | $2.55 |
Enterprise Value | $202.02B | $10.82B |
Dividend Yield | 2.51% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $105.9, up 1.68% recently, with a bullish technical signal and strong analyst support (84.6% buy ratings). The company has beaten earnings estimates for three consecutive quarters, including Q1 2026 EPS of $2.57 versus $2.18 expected. Revenue growth remains robust, reaching $402.07B in 2025, though net margins are thin at 0.72%. Recent news highlights a settlement with the FTC advancing prescription drug affordability initiatives.
The outlook is positive given earnings momentum and strategic positioning in healthcare services, but risks include regulatory pressures and margin compression. The consensus price target of $110.62 suggests modest upside from current levels, supported by dividend payments and institutional confidence.
Transocean Ltd. (RIG) trades at $5.37, up 3.27% today, with a bullish technical signal from moving averages. The company reported a net loss of $2.92 billion in 2025, but revenue grew to $3.97 billion, and recent contract wins, including a $1 billion deal with Equinor, bolster its backlog. The pending merger with Valaris Limited aims to reduce leverage and unlock synergies.
The outlook is mixed; analyst consensus is a Buy with a $7.00 price target, but persistent net losses and high debt pose risks. Upside depends on successful merger integration and improved profitability, while oil price volatility and execution challenges remain key concerns for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Transocean Ltd
Transocean Ltd. is a leading international provider of offshore contract drilling services for oil and gas wells. The company operates one of the world's most versatile fleets of mobile offshore drilling units, including ultra-deepwater drillships and harsh environment semi-submersibles. RIG's services are essential to energy exploration and production companies seeking to access deepwater and challenging reserves globally.
Read more on RIG →
